We read with great interest the recent article CD-1 and Balb/cJ mice do not show enduring antidepressant-like effects of ketamine in tests of acute antidepressant efficacy by Bechtholt-Gompf et al. (in press). In that study, the tail suspension test (TST) and forced swimming test (FST) were not sensitive to long-lasting antidepressant-like effects of ketamine in mice. We appreciate this study and would like to discuss an issue relevant to this article.
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The authors administrated high-dose ketamine to observe the behavioral changes in the FST and TST. However, the administration of ketamine 25 mg/kg induces an immediate behavioral activation, characterized by hyperlocomotion, stereotypies, and ataxia in rats (Razoux et al. 2007) , suggesting that ketamine exceeding 25 mg/kg tends to elicit schizophrenia-like manifestations. Similarly, in that study, the authors did not investigate the motor behavior before FST and TST. Although a citation was provided by the authors in the discussion that the effective dose (10, 50 mg/ kg) of ketamine, instead of high dose, did not affect general locomotor activity, in either the plus-maze or the open field test (Engin et al. 2009 ). On the other hand, low-dose ketamine was commonly used to investigate its antidepressant effect in experimental studies and was recommended to ameliorate the symptoms of patients with depression (Machado-Vieira et al. 2009 ). Thus, we assumed that highdose ketamine may be not very suitable to investigate its antidepressant effect.
